M, D., KS, M., LO, D., SF, L., E, W., D, O., . . . J, T. (2024). Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection. The lancet. Gastroenterology & hepatology, 9(4), 383. https://doi.org/10.1016/S2468-1253(23)00315-1
Chicago Style (17th ed.) CitationM, Delphin, et al. "Under-representation of the WHO African Region in Clinical Trials of Interventions Against Hepatitis B Virus Infection." The Lancet. Gastroenterology & Hepatology 9, no. 4 (2024): 383. https://doi.org/10.1016/S2468-1253(23)00315-1.
MLA (9th ed.) CitationM, Delphin, et al. "Under-representation of the WHO African Region in Clinical Trials of Interventions Against Hepatitis B Virus Infection." The Lancet. Gastroenterology & Hepatology, vol. 9, no. 4, 2024, p. 383, https://doi.org/10.1016/S2468-1253(23)00315-1.